外耳炎

Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504].全文  摘要

Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992 May-Jun;13(3):145-55. 摘要

Jackson EA, Geer K. Acute otitis externa: rapid evidence review. Am Fam Physician. 2023 Feb;107(2):145-51. 摘要

Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994 May;15(3):408-12. 摘要

1. Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504].全文  摘要

2. Browning GG. Aetiopathology of inflammatory conditions of the external and middle ear. In: Kerr AG, ed. Scott-Brown's Otolaryngology. Oxford, UK: Butterworth-Heinemann; 1997.

3. Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992 May-Jun;13(3):145-55. 摘要

4. Lee SK, Lee SA, Seon SW, et al. Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol. 2017 Sep;10(3):228-35.全文  摘要

5. Walshe P, Cleary M, McConn WR, et al. Malignant otitis externa: a high index of suspicion is still needed for diagnosis. Irish Med J. 2002 Jan;95(1):14-6. 摘要

6. Johnson AK, Batra PS. Central skull base osteomyelitis: an emerging clinical entity. Laryngoscope. 2014 May;124(5):1083-7. 摘要

7. Frost J, Samson AD. Standardised treatment protocol for necrotizing otitis externa: retrospective case series and systematic literature review. J Glob Antimicrob Resist. 2021 Sep;26:266-71.全文  摘要

8. Kiakojuri K, Mahdavi Omran S, Roodgari S, et al. Molecular identification and antifungal susceptibility of yeasts and molds isolated from patients with otomycosis. Mycopathologia. 2021 May;186(2):245-57. 摘要

9. Aboutalebian S, Ahmadikia K, Fakhim H, et al. Direct detection and identification of the most common bacteria and fungi causing otitis externa by a stepwise multiplex PCR. Front Cell Infect Microbiol. 2021;11:644060.全文  摘要

10. Koltsidopoulos P, Skoulakis C. Otomycosis with tympanic membrane perforation: a review of the literature. Ear Nose Throat J. 2020 Sep;99(8):518-21.全文  摘要

11. Alshahni MM, Alshahni RZ, Fujisaki R, et al. A case of topical ofloxacin-induced otomycosis and literature review. Mycopathologia. 2021 Dec;186(6):871-6. 摘要

12. Jackson EA, Geer K. Acute otitis externa: rapid evidence review. Am Fam Physician. 2023 Feb;107(2):145-51. 摘要

13. Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994 May;15(3):408-12. 摘要

14. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002 Jul;112(7 Pt 1):1166-77. 摘要

15. Rowlands S, Devalia H, Smith C, et al. Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract. 2001 Jul;51(468):533-8.全文  摘要

16. Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician. 2012 Dec 1;86(11):1055-61.全文  摘要

17. Livingstone DM, Smith KA, Lange B. Scuba diving and otology: a systematic review with recommendations on diagnosis, treatment and post-operative care. Diving Hyperb Med. 2017 Jun;47(2):97-109. 摘要

18. Barry V, Bhamra N, Balai E, et al. Otitis externa. BMJ. 2021 Mar 31;372:n714.全文  摘要

19. Schwartz SR, Magit AE, Rosenfeld RM, et al. Clinical practice guideline (update): earwax (cerumen impaction). Otolaryngol Head Neck Surg. 2017 Jan;156(1_suppl):S1-29.全文  摘要

20. Moss WJ, Finegersh A, Narayanan A, et al. Meta-analysis does not support routine traditional nuclear medicine studies for malignant otitis. Laryngoscope. 2020 Jul;130(7):1812-6. 摘要

21. Stern Shavit S, Bernstine H, Sopov V, et al. FDG-PET/CT for diagnosis and follow-up of necrotizing (malignant) external otitis. Laryngoscope. 2019 Apr;129(4):961-6. 摘要

22. Hodgson SH, Khan MM, Patrick-Smith M, et al. UK consensus definitions for necrotising otitis externa: a Delphi study. BMJ Open. 2023 Feb 20;13(2):e061349.全文  摘要

23. Chan KL, Soo G, van Hasselt CA. Furunculosis. Ear Nose Throat J. 1997 Mar;76(3):126. 摘要

24. Dubach P, Mantokoudis G, Caversaccio M. Ear canal cholesteatoma: meta-analysis of clinical characteristics with update on classification, staging and treatment. Curr Opin Otolaryngol Head Neck Surg. 2010 Oct;18(5):369-76. 摘要

25. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest. 2004 Mar;113(5):651-7.全文  摘要

26. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015 Feb 1;91(3):185-90.全文  摘要

27. List T, Jensen RH. Temporomandibular disorders: old ideas and new concepts. Cephalalgia. 2017 Jun;37(7):692-704.全文  摘要

28. Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015 Mar 12;350:h1154.全文  摘要

29. Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004740.全文  摘要

30. Kantas I, Balatsouras DG, Vafiadis M, et al. The use of trichloroacetic acid in the treatment of acute external otitis. Eur Arch Otorhinolaryngol. 2007 Jan;264(1):9-14. 摘要

31. Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003 Apr;22(4):299-305;quiz 306-8. 摘要

32. van Balen FA, Smit WM, Zuithoff NP, et al. Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial. BMJ. 2003 Nov 22;327(7425):1201-5.全文  摘要

33. Lambert IJ. A comparison of the treatment of otitis externa with "Otosporin" and aluminium acetate: a report from a services practice in Cyprus. J R Coll Gen Pract. 1981 May;31(226):291-4.全文  摘要

34. Mösges R, Schröder T, Baues CM, et al. Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa. Curr Med Res Opin. 2008 Aug;24(8):2339-47. 摘要

35. Pistorius B, Westberry K, Drehobl M, et al. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract. 1999;8:387-95.

36. Jones RN, Milazzo J, Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg. 1997 Nov;123(11):1193-200. 摘要

37. Wall GM, Stroman DW, Roland PS, et al. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Pediatr Infect Dis J. 2009 Feb;28(2):141-4. 摘要

38. Mösges R, Nematian-Samani M, Hellmich M, et al. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa. Curr Med Res Opin. 2011 Oct;27(10):2053-60. 摘要

39. Wang X, Winterstein AG, Alrwisan A, et al. Risk for tympanic membrane perforation after quinolone ear drops for acute otitis externa. Clin Infect Dis. 2020 Mar 3;70(6):1103-9.全文  摘要

40. Rahman A, Rizwan S, Waycaster C, et al. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children. Clin Ther. 2007 Sep;29(9):1950-6. 摘要

41. Roland PS, Belcher BP, Bettis R, et al; Cipro HC Study Group. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. Am J Otolaryngol. 2008 Jul-Aug;29(4):255-61. 摘要

42. Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000 Jun;122(6):934-40. 摘要

43. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication].全文

44. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. March 2019 [internet publication].全文

45. US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 2016 [internet publication].全文

46. US Food and Drug Administration. FDA drug safety communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication].全文

47. US Food and Drug Administration. FDA drug safety communication: FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. July 2018 [internet publication].全文

48. Hopkins ME, Bennett A, Henderson N, et al. A retrospective review and multi-specialty, evidence-based guideline for the management of necrotising otitis externa. J Laryngol Otol. 2020 Jun;134(6):487-92. 摘要

49. Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008 Jun;41(3):537-49;viii-ix. 摘要

50. Bernstein JM, Holland NJ, Porter GC, et al. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol. 2007 Feb;121(2):118-23. 摘要

51. Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):316-23. 摘要

52. Franco-Vidal V, Blanchet H, Bebear C, et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007 Sep;28(6):771-3. 摘要

53. Amaro CE, Espiney R, Radu L, et al. Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre. Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1881-7. 摘要

54. Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2013 May 31;(5):CD004617.全文  摘要

55. Hajioff D, Mackeith S. Otitis externa. BMJ Clin Evid. 2010 Aug 3;2010:0510.全文  摘要

56. Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005 Nov;69(11):1503-8. 摘要

57. Mion M, Bovo R, Marchese-Ragona R, et al. Outcome predictors of treatment effectiveness for fungal malignant external otitis: a systematic review. Acta Otorhinolaryngol Ital. 2015 Oct;35(5):307-13.全文  摘要

58. Abou-Halawa AS, Khan MA, Alrobaee AA, et al. Otomycosis with perforated tympanic membrane: self medication with topical antifungal solution versus medicated ear wick. Int J Health Sci (Qassim). 2012 Jan;6(1):73-7.全文  摘要

59. Görür K, İsmi O, Özcan C, et al. Treatment of otomycosis in ears with tympanic membrane perforation is easier with paper patch. Turk Arch Otorhinolaryngol. 2019 Dec;57(4):182-6.全文  摘要

60. Demir D, Yılmaz MS, Güven M, et al. Comparison of clinical outcomes of three different packing materials in the treatment of severe acute otitis externa. J Laryngol Otol. 2018 Jun 13;132(6):523-8. 摘要

61. US Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication].全文

62. Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication].全文

63. European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication].全文

64. Ali T, Meade K, Anari S, et al. Malignant otitis externa: case series. J Laryngol Otol. 2010 Aug;124(8):846-51. 摘要